FCF Yield

Abbott Laboratories’ current free cash flow (FCF) yield of 3.4% means that for every dollar you invest in the stock, the company generates about 3.4 cents in free cash flow per year — a measure of the cash left after operating expenses and capital spending.

This yield sits below the healthcare sector median of 4.5%, placing Abbott at the 29th percentile among its peers, indicating it offers less cash return relative to stock price than most competitors. The metric has been perfectly stable over the last eight quarters, with a year-over-year change of +0.0% and a quarter-over-quarter change of +0.0%. The combination of a below-median yield and a flat trend suggests limited upside from cash generation alone, but also no deterioration — making the risk-return profile moderate rather than compelling. This overall picture supports the NEUTRAL verdict: the FCF yield does not signal a strong buying opportunity nor a reason to sell, consistent with a balanced assessment.

Frequently Asked Questions

Closest Sector Peers